AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

NIH

Together on the Pathways to Wellness: Recovery and Efforts to Strengthen Viral Hepatitis Services

Ronald Valdiserri

Throughout September’s observance of National Recovery Month, individuals, organizations, and communities across the nation celebrated recovery from mental health issues and addiction challenges. Given the significant role that drug-using behaviors can play in the transmission of viral hepatitis, and the fact that alcohol intake often worsens liver disease among persons with chronic viral hepatitis, National Recovery…

Dr. Carl Dieffenbach: Key Developments in HIV Research from IAS 2013

IAS Day 2

Last week, Dr. Carl Dieffenbach from NIH/NIAID shared brief reports from the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention (IAS 2013) with the AIDS.gov community via Skype. As Dr. Dieffenbach related, some key highlights of the conference included: Long-term HIV treatment strategies to address HIV as a chronic management disease; The…

Highlights from the 7th International AIDS Society (IAS) Conference Opening Session

International AIDS Society Day 1

June 30, 2013, was the opening plenary of the 7th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment, and Prevention in Kuala Lampur, Malaysia. We asked Dr. Carl Dieffenbach, Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases (NIAID), to share highlights from the conference via Skype. Please…

NIH Scientists Discover How HIV Kills Immune Cells

NIAID

FOR IMMEDIATE RELEASE Wednesday, June 5, 2013 MEDIA AVAILABILITY NIH Scientists Discover How HIV Kills Immune Cells Findings Have Implications for HIV Treatment WHAT: Untreated HIV infection destroys a person’s immune system by killing infection-fighting cells, but precisely when and how HIV wreaks this destruction has been a mystery until now. New research by scientists…

NIDA Research Seeks to Reduce Viral Hepatitis Caused by Drug Use Behaviors

Compton & Khalsa

Hepatitis C virus (HCV) is the leading cause of liver failure and liver transplantation in the United States and people who inject drugs (PWID) are particularly susceptible to this disease with as many as 70% or more of this population testing positive for the virus. To make matters worse, PWID enjoy little if any consistent…

HIV Vaccine Awareness Day Bulletin

HVAD Logo

The implementation of scientifically proven HIV prevention strategies is helping to reduce the number of new infections — the annual HIV infection rate globally fell by 22 percent from 2001 to 2011 — but a great deal more must be done. Significant scale-up of proven HIV prevention strategies coupled with the discovery of new HIV…

May 18th HIV Vaccine Awareness Day (HVAD): A Conversation with Dr. Carl Dieffenbach

HVAD Logo

May 18th is HIV Vaccine Awareness Day (HVAD), led by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. We spoke to Dr. Carl Dieffenbach at NIH, who had this to say about HIV Vaccine Awareness Day: “[On Vaccine Awareness Day] we can take a moment to acknowledge the…

New NIH Award Aims to Reduce Asian American Hepatitis B Disparities through Health Information Technology

Ronald Valdiserri

A new grant award by the National Institute on Minority Health and Health Disparities (NIMHD) will support the development of new Health Information Technology (HIT) strategies that increase screening for chronic hepatitis B and reduce the impact of hepatitis B among high-risk Asian American and Pacific Islander (AAPI) populations.  Hepatitis B virus (HBV) infection is…